SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-088604
Filing Date
2023-08-08
Accepted
2023-08-08 07:32:40
Documents
12
Period of Report
2023-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323116d1_8k.htm   iXBRL 8-K 23504
  Complete submission text file 0001104659-23-088604.txt   195941

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rytm-20230804.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20230804_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20230804_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2323116d1_8k_htm.xml XML 3320
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 231149351
SIC: 2834 Pharmaceutical Preparations